SEC Form 4 · accession 0001127602-18-026465
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D Haytaian
Officer — EVP & President, Commercial
Period of report
Aug 27, 2018
Accepted (ET)
Aug 29, 2018 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 27, 2018 | S | 2,532 | $265.70 | D | 57,674 | D | |
| Common Stock | Aug 27, 2018 | S | 968 | $266.50 | D | 56,706 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- F2This transaction was executed in multiple trades at prices ranging from $265.44 to $266.37. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.